Scientists at M.D. Anderson Cancer Center at the University of Texas have found that women with ovarian cancer who have low levels of critical RNAi proteins, Dicer and Drosha, die faster than those with high levels, says a story in The Wall Street Journal. Examining protein levels in 250 women with ovarian cancer, scientists led by Anil Sood found that women with high levels of Dicer and Drosha had a median survival of 11 years while women with low levels of one or both had a median survival of less than three years. Researchers hope to begin testing RNAi therapy on humans next year.
Two More to the RNAi Therapeutics List
Dec 19, 2008